Correlation Between Biofrontera Warrants and Acurx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Biofrontera Warrants and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Acurx Pharmaceuticals.
Diversification Opportunities for Biofrontera Warrants and Acurx Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Biofrontera and Acurx is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Acurx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biofrontera Warrants and Acurx Pharmaceuticals
Assuming the 90 days horizon Biofrontera Warrants is expected to generate 19.78 times more return on investment than Acurx Pharmaceuticals. However, Biofrontera Warrants is 19.78 times more volatile than Acurx Pharmaceuticals LLC. It trades about 0.14 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.01 per unit of risk. If you would invest 34.00 in Biofrontera Warrants on September 2, 2024 and sell it today you would lose (21.00) from holding Biofrontera Warrants or give up 61.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 64.92% |
| Values | Daily Returns |
Biofrontera Warrants vs. Acurx Pharmaceuticals LLC
Performance |
| Timeline |
| Biofrontera Warrants |
| Acurx Pharmaceuticals LLC |
Biofrontera Warrants and Acurx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biofrontera Warrants and Acurx Pharmaceuticals
The main advantage of trading using opposite Biofrontera Warrants and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.| Biofrontera Warrants vs. Biofrontera | Biofrontera Warrants vs. Pasithea Therapeutics Corp | Biofrontera Warrants vs. Inspira Technologies Oxy | Biofrontera Warrants vs. Bluejay Diagnostics |
| Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |